---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-019941"
form_type: "8-K"
ticker: "MGRX"
cik: "0001938046"
company_name: "MANGOCEUTICALS, INC."
filed_at: "2025-10-29T23:59:59+00:00"
generated_at: "2026-05-17T01:44:21.014886+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Mangoceuticals leases Dallas office and separates from COO Hammer with severance

## Summary
- Enters 5-year lease for 2,467 sq ft Suite 245 at 17130 Dallas Parkway; base rent $4,852/mo + operating expenses.
- COO Amanda Hammer terminated effective Oct 22, 2025; receives 9 months' salary in equal installments starting Nov 1, 2025.
- Indigo Capital LP converts 500 Series B shares ($500,000 stated value) into 366,667 common shares at $1.50/sh conversion price.
- Platinum Point Capital converts 32 Series B shares ($35,200 stated value) into 23,466 common shares on Oct 16, 2025.
- Employment agreement with Hammer terminated; no material termination penalties incurred beyond severance.

## SEC filing metadata
- accession: 0001493152-25-019941
- form_type: 8-K
- ticker: MGRX
- cik: 0001938046
- company_name: MANGOCEUTICALS, INC.
- filed_at: 2025-10-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 3.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938046/000149315225019941/0001493152-25-019941-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938046/000149315225019941/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-019941
- JSON: https://secwatch.observer/filing/0001493152-25-019941.json
- Plain text: https://secwatch.observer/filing/0001493152-25-019941.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.